{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:24Z","timestamp":1791489624367,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":256,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100222"],"award-info":[{"award-number":["82100222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101445","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:53:53Z","timestamp":1789851233000},"page":"101445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and prognostic significance of CD4 expression in patients with de novo acute myeloid leukemia receiving intensive chemotherapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Liu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchen","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqiong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3989-1528","authenticated-orcid":false,"given":"Pan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101445_bib0001","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/ajh.27625","article-title":"Acute Myeloid Leukemia: 2025 update on diagnosis, risk-stratification, and management","volume":"100","author":"Shimony","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0002","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101445_bib0003","first-page":"1703","volume":"36","author":"Khoury","year":"2022"},{"key":"10.1016\/j.ctarc.2026.101445_bib0004","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101445_bib0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101445_bib0006","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4939-9650-6_15","article-title":"Immunophenotyping of acute myeloid leukemia","volume":"2032","author":"Galera","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cll.2017.07.003","article-title":"Acute myeloid leukemia immunophenotyping by flow cytometric analysis","volume":"37","author":"Chen","year":"2017","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.ctarc.2026.101445_bib0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cyto.b.22230","article-title":"Unraveling genotype-phenotype associations and predictive modeling of outcome in acute myeloid leukemia","volume":"108","author":"Couckuyt","year":"2025","journal-title":"Cytometry. B Clin. Cytom."},{"key":"10.1016\/j.ctarc.2026.101445_bib0009","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3324\/haematol.2022.282034","article-title":"The present and future of measurable residual disease testing in acute myeloid leukemia","volume":"107","author":"Blachly","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.ctarc.2026.101445_bib0010","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3324\/haematol.2011.047894","article-title":"High levels of CD34+CD38low\/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study","volume":"96","author":"Vergez","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ctarc.2026.101445_bib0011","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1186\/s12885-022-10460-3","article-title":"Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia","volume":"22","author":"Liang","year":"2022","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.ctarc.2026.101445_bib0012","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1111\/bjh.19446","article-title":"Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression","volume":"204","author":"Jen","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0013","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hon.2331","article-title":"Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia","volume":"35","author":"Chisini","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0014","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/bjh.16080","article-title":"Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1-positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia\/Lymphoma study group AML-05 study","volume":"187","author":"Sakamoto","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cyto.b.10030","article-title":"Immunophenotyping is an independent factor for risk stratification in AML","volume":"53B","author":"Repp","year":"2003","journal-title":"Cytometry. B Clin. Cytom."},{"key":"10.1016\/j.ctarc.2026.101445_bib0016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/10428190802123994","article-title":"Expression patterns of CD33 and CD15 predict outcome in patients with acute myeloid leukemia","volume":"49","author":"Derolf","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ctarc.2026.101445_bib0017","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/ijlh.12649","article-title":"Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia","volume":"39","author":"Guo","year":"2017","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112684","article-title":"Immunophenotypic dissection of normal hematopoiesis","volume":"475","author":"Orfao","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ctarc.2026.101445_bib0020","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3389\/fimmu.2013.00495","article-title":"Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment","volume":"4","author":"Jardine","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0021","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/v12101077","article-title":"Macrophage tropism in pathogenic HIV-1 and SIV infections","volume":"12","author":"Moeser","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ctarc.2026.101445_bib0022","article-title":"Multi-omics integration of molecular genetics, cytogenetics and immunophenotyping: a novel prognostic model for immune landscape characterization and outcome prediction in Chinese patients with acute myeloid leukemia","volume":"17","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0023","first-page":"12","article-title":"Acute myeloid leukemia: aging and epigenetics","author":"Zjablovskaja","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101445_bib0024","article-title":"Aging and comprehensive molecular profiling in acute myeloid leukemia","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"key":"10.1016\/j.ctarc.2026.101445_bib0025","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1080\/10428190701713622","article-title":"Estimated number of cases, regional distribution and survival of patients diagnosed with acute myeloid leukemia between 1996 and 2000 in Rio Grande do Sul, Brazil","volume":"48","author":"Capra","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ctarc.2026.101445_bib0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.13406","article-title":"Acute myeloid leukaemia: challenges and real world data from India","volume":"170","author":"Philip","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ctarc.2026.101445_bib0027","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.ctarc.2026.101445_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278578","article-title":"Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: a systematic review","volume":"17","author":"Hao","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101445_bib0029","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cncr.23219","article-title":"Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience","volume":"112","author":"Plesa","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2026.101445_bib0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/10245332.2016.1276240","article-title":"CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia","volume":"22","author":"Fujiwara","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.ctarc.2026.101445_bib0031","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.21873\/anticanres.17083","article-title":"Association of CD38+ immunophenotyping biomarker with a better prognosis in elderly acute myeloid leukemia patients","volume":"44","author":"DE Pinho Pessoa","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ctarc.2026.101445_bib0032","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41408-025-01416-4","article-title":"Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study","volume":"15","author":"Salter","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ctarc.2026.101445_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.leu.2400877","article-title":"Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin","volume":"12","author":"Miwa","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101445_bib0034","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/bloodadvances.2021004292","article-title":"Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia","volume":"6","author":"Wakita","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.ctarc.2026.101445_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.123","article-title":"Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: results of the AML Study Group (AMLSG)","volume":"8","author":"Rucker","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.ctarc.2026.101445_bib0036","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/blood.2020009680","article-title":"CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome","volume":"139","author":"Taube","year":"2022","journal-title":"Blood"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:39:03Z","timestamp":1791488343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"alternative-id":["S2468294226003552"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101445","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and prognostic significance of CD4 expression in patients with de novo acute myeloid leukemia receiving intensive chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101445"}}